These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 3532452
21. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A. Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [Abstract] [Full Text] [Related]
22. T cell subsets in the immune rejection of murine heterotopic corneal allografts. Matoba AY, Peeler JS, Niederkorn JY. Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516 [Abstract] [Full Text] [Related]
24. Frequency of alloantigen-specific T cytotoxic cells in high- and low-responder recipients of class I MHC-disparate heart allografts. Stepkowski SM, Ito T. Transplantation; 1990 Jul; 50(1):112-9. PubMed ID: 2368131 [Abstract] [Full Text] [Related]
25. Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts. Padberg WM, Lord RH, Di Stefano R, Araneda D, Tilney NL, Kupiec-Weglinski JW. Transplantation; 1988 Jan; 45(1):162-8. PubMed ID: 3276045 [Abstract] [Full Text] [Related]
26. Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts. Moliterno R, Valdivia L, Pan F, Duquesnoy RJ. Transplantation; 1995 Feb 27; 59(4):598-604. PubMed ID: 7878764 [Abstract] [Full Text] [Related]
27. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat. Lowry RP, Forbes RD, Blackburn JH, Marghesco DM. Transplantation; 1985 Nov 27; 40(5):545-50. PubMed ID: 3904091 [Abstract] [Full Text] [Related]
28. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Transplantation; 1993 May 27; 55(5):1112-8. PubMed ID: 8497891 [Abstract] [Full Text] [Related]
29. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients. Heidecke CD, Zantl N, Maier S, Sewczik T, Westerholt S, Jakobs F, Westerholt A, Hancock WW, Kupiec-Weglinski JW. Transplantation; 1998 Nov 27; 66(10):1354-61. PubMed ID: 9846522 [Abstract] [Full Text] [Related]
30. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody. Schneider TM, Kupiec-Weglinski JW, Towpik E, Padberg W, Araneda D, Diamantstein T, Strom TB, Tilney NL. Transplantation; 1986 Aug 27; 42(2):191-6. PubMed ID: 2943063 [Abstract] [Full Text] [Related]
31. Host-graft relationship: the systemic nature of allograft rejection. Kupiec-Weglinski JW, Araujo JL, Towpik E, Araneda D, Tilney NL. Surgery; 1985 Aug 27; 98(2):259-66. PubMed ID: 3895538 [Abstract] [Full Text] [Related]
32. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H, Leamer M, Wang HK, Makowka L, Cramer DV. Transplantation; 1995 Feb 15; 59(3):401-10. PubMed ID: 7871571 [Abstract] [Full Text] [Related]
34. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K, Hardy MA, Oluwole SF. Transplantation; 1995 Oct 27; 60(8):806-11. PubMed ID: 7482739 [Abstract] [Full Text] [Related]
35. Difference of rejection between heart and heart-lung transplantation in rats: flowcytometric analysis of graft infiltrating lymphocyte subsets. Okada M, Senoo Y, Teramoto S. Acta Med Okayama; 1992 Feb 27; 46(1):37-44. PubMed ID: 1561904 [Abstract] [Full Text] [Related]
36. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. Yamaguchi Y, Mori K, Bollinger RR. J Clin Lab Immunol; 1990 Jun 27; 32(2):59-66. PubMed ID: 1967040 [Abstract] [Full Text] [Related]
37. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, Chun HJ, Liu K, Kim YM, Murase N. Liver Transpl; 2000 Nov 27; 6(6):686-702. PubMed ID: 11084053 [Abstract] [Full Text] [Related]
38. Irradiated spleen allografts: an ideal model for the study of infiltrating effector cells. Duncan WR, Stepkowski S, Bitter-Suermann H. Transplant Proc; 1985 Aug 27; 17(4):1991-3. PubMed ID: 3875173 [No Abstract] [Full Text] [Related]
39. W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients. Padberg WM, Kupiec-Weglinski JW, Lord RH, Towpik E, Tilney NL. Transplant Proc; 1987 Feb 27; 19(1 Pt 1):493-4. PubMed ID: 3274813 [No Abstract] [Full Text] [Related]
40. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD, Van Breda Vriesman PJ. Transplantation; 1983 Feb 27; 35(2):121-6. PubMed ID: 6338632 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]